Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: A randomised controlled trial

Heart

Volumn 100, Issue 14, 2014, Pages 1085-1092

  Higgins, P ^a   Walters, M R ^a   Murray, H M ^a   McArthur, K ^a   McConnachie, A ^a   Lees, K R ^a   Dawson, J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; PLACEBO; URIC ACID;

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; BRACHIAL PRESSURE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CENTRAL BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTHELIUM; ENDOTHELIUM FUNCTION; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; URIC ACID BLOOD LEVEL;

PHARMACOLOGY;

AGED; ALLOPURINOL; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY MASS INDEX; BRACHIAL ARTERY; BRAIN ISCHEMIA; CAROTID INTIMA-MEDIA THICKNESS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; STROKE; TREATMENT OUTCOME;

EID: 84903433154     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-305683     Document Type: Article

References (29)

1. Sacco RL, Diener HC, Yusuf S, et al.; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238-51.
2. Cameron AC, Dawson J, Quinn TJ, et al. Long-term outcome following attendance at a transient ischemic attack clinic. Int J Stroke 2011;6:306-11.
3. Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol 2006;62:633-44. (Pubitemid 44754682)
4. Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34:1951-6. (Pubitemid 36944787)
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000;87:840-4.
6. George J, Carr E, Davies J, et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006;114:2508-16. (Pubitemid 44901524)
7. Higgins P, Dawson J, Lees KR, et al. Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther 2012;30:217-26.
8. Khan F, George J, Wong K, et al. Allopurinol treatment reduces arterial wave reflection in stroke survivors. Cardiovasc Ther 2008;26:247-52.
9. Muir SW, Harrow C, Dawson J, et al. Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2008;39:3303-7.
10. Dawson J, Quinn T, Harrow C, et al. Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial. Diabetes Care 2009;32:135-7.
11. Rekhraj S, Gandy SJ, Szwejkowski BR, et al. High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease. J Am Coll Cardiol 2013;61:926-32.
12. Noman A, Ang DS, Ogston S, et al. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010;375:2161-7.
13. Bots ML, Evans GW, Riley WA, et al. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 2003;34:2985-94. (Pubitemid 37517782)
14. Amarenco P, Labreuche J, Lavallee P, et al. Statins in stroke prevention and carotid atherosclerosis. Systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-9. (Pubitemid 39565192)
15. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertension 1996;14:S147-57. (Pubitemid 27051090)
16. Stein JH, Korcarz CE, Hurst RT, et al.; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008;21:93-111. (Pubitemid 351193107)
17. Pini R, Cavallini MC, Palmieri V, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 2008;51:2432-9. (Pubitemid 351815169)
18. Williams B, Lacy PS, Thom SM, et al.; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1213-25.
19. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007;50:197-203. (Pubitemid 46986041)
20. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008;300:924-32.
21. Wilkinson IB, MacCallum H, Cockcroft JR, et al. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 2002;53:189-92. (Pubitemid 34264274)
22. Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005;12:3553-62.
23. De Scheerder IK, van de Kraay AM, Lamers JM, et al. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: potential mechanisms for free radical generation. Am J Cardiol 1991;68:392-5.
24. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67. (Pubitemid 46184197)
25. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9. (Pubitemid 28090756)
26. Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008;358:1431-43. (Pubitemid 351482735)
27. Bots ML, Taylor AJ, Kastelein JP, et al. Rate of change in carotid-intima media thickness and vascular events: meta-analyses cannot solve all the issues. A point of view. J Hypertension 2012;30:1690-6.
28. Hare JM, Mangal B, Brown J, et al.; OPT-CHF Investigators. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 2008;51:2301-9. (Pubitemid 351783365)
29. El Solh AA, Saliba R, Bosinski T, et al. Allopurinol improves endothelial function in sleep apnoea: a randomized controlled study. Eur Respir J 2006;27:997-1002. (Pubitemid 44911115)